日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies

合成病毒学方法可提高溶瘤病毒疗法的安全性和有效性

Taha Azad #, Reza Rezaei #, Ragunath Singaravelu, Adrian Pelin, Stephen Boulton, Julia Petryk, Kemal Alper Onsu, Nikolas T Martin, Victoria Hoskin, Mina Ghahremani, Marie Marotel, Ricardo Marius, Xiaohong He, Mathieu J F Crupi, Huy-Dung Hoang, Abolfazl Nik-Akhtar, Mahsa Ahmadi, Nika Kooshki Zamani, 

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX

CRISPR 介导的痘病毒载体快速武装可以轻松生成新型免疫治疗药物 STINGPOX

Jack T Whelan, Ragunath Singaravelu, Fuan Wang, Adrian Pelin, Levi A Tamming, Giuseppe Pugliese, Nikolas T Martin, Mathieu J F Crupi, Julia Petryk, Bradley Austin, Xiaohong He, Ricardo Marius, Jessie Duong, Carter Jones, Emily E F Fekete, Nouf Alluqmani, Andrew Chen, Stephen Boulton, Michael S Huh, 

Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy

基于 Split-T7 聚合酶设计雷帕霉素类似物诱导基因开关,以调节溶瘤病毒驱动的肿瘤定位 IL-12 的产生,用于抗癌免疫治疗

Nikolas T Martin, Mathieu J F Crupi, Zaid Taha, Joanna Poutou, Jack T Whelan, Sydney Vallati, Julia Petryk, Ricardo Marius, Bradley Austin, Taha Azad, Mason Boulanger, Tamara Burgess, Ilson Sanders, Camille Victoor, Bryan C Dickinson, Jean-Simon Diallo, Carolina S Ilkow, John C Bell

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection

单剂量复制型痘病毒载体 RBD 疫苗可激发针对 SARS-CoV-2 感染的强大体液和 T 细胞免疫反应

Stephen Boulton, Joanna Poutou, Nikolas T Martin, Taha Azad, Ragunath Singaravelu, Mathieu J F Crupi, Taylor Jamieson, Xiaohong He, Ricardo Marius, Julia Petryk, Christiano Tanese de Souza, Bradley Austin, Zaid Taha, Jack Whelan, Sarwat T Khan, Adrian Pelin, Reza Rezaei, Abera Surendran, Sarah Tucke

Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry

基于纳米荧光素酶互补的生物报告基因揭示了 SARS-CoV-2 S 的 N 连接糖基化对病毒进入的重要性

Taha Azad, Ragunath Singaravelu, Zaid Taha, Taylor R Jamieson, Stephen Boulton, Mathieu J F Crupi, Nikolas T Martin, Emily E F Fekete, Joanna Poutou, Mina Ghahremani, Adrian Pelin, Kazem Nouri, Reza Rezaei, Christopher Boyd Marshall, Masahiro Enomoto, Rozanne Arulanandam, Nouf Alluqmani, Reuben Sams

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization

对 SARS-CoV-2 疫苗设计的影响:刺突糖蛋白跨膜结构域与受体结合结构域融合诱导三聚化

Taha Azad, Ragunath Singaravelu, Mathieu J F Crupi, Taylor Jamieson, Jaahnavi Dave, Emily E F Brown, Reza Rezaei, Zaid Taha, Stephen Boulton, Nikolas T Martin, Abera Surendran, Joanna Poutou, Mina Ghahremani, Kazem Nouri, Jack T Whelan, Jessie Duong, Sarah Tucker, Jean-Simon Diallo, John C Bell, Car

Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy

抗体的分子重定向可将针对溶瘤病毒的免疫防御转化为癌症免疫疗法

Julia Niemann ,Norman Woller ,Jennifer Brooks ,Bettina Fleischmann-Mundt ,Nikolas T Martin ,Arnold Kloos ,Sarah Knocke ,Amanda M Ernst ,Michael P Manns ,Stefan Kubicka ,Thomas C Wirth ,Rita Gerardy-Schahn ,Florian Kühnel